U.S. Securities and Exchange Commission

                            Washington, D.C. 20549


                                 FORM 10-QSB

 (Mark One)
   [ X ]    QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
            EXCHANGE ACT OF 1934

            For the quarterly period ended June 30, 2003

   [   ]    TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
            EXCHANGE ACT OF 1934

            For the transition period from                    to

            Commission file number: 000-26740

                         AMERICAN HEALTHCHOICE, INC.
      (Exact name of small business issuer as specified in its charter)

                 New York                                    11-2931252
      (State or other jurisdiction of                     (I.R.S. Employer
       incorporation or organization)                   Identification No.)

      2221 Justin Road, Suite 119-154, Flower Mound, TX        75028
         (Address of principal executive offices)            (Zip Code)

                                (972) 538-0122
                         (Issuer's telephone number)

      Check whether the issuer (1) filed all reports required to be filed by
 Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
 such shorter period that the registrant was required to file such reports),
 and (2) has been subject to such filing requirements for the past 90 days.

      Yes [ X ]       No [   ]

      As of June 30, 2003, there were outstanding 88,100,766 shares of the
 issuer's Common Stock, par value $.001 per share.

 Transitional Small Business Disclosure Format (check one)

      Yes [   ]      No [ X ]

<PAGE>

                         AMERICAN HEALTHCHOICE, INC.

                             INDEX TO FORM 10-QSB

                     For the Quarter Ended June 30, 2003



       Part I Financial Information

         Item 1.  Financial Statements

            Consolidated Balance Sheet .....................          2

            Consolidated Statement of Operations ...........          3

            Consolidated Statement of Cash Flows ...........          4

            Notes to Consolidated Financial Statements .....          5


         Item 2.  Management's Discussion and Analysis or
                  Plan of Operation ........................          6


       Part II Other Information

         Item 1.  Legal Proceedings ........................          8

         Item 2.  Changes in Securities and Use of Proceeds           8

         Item 3.  Defaults upon Senior Securities ..........          8

         Item 4.  Submission of Matters to a Vote of
                  Security Holders..........................          8

         Item 5.  Other Information ........................          8

         Item 6.  Exhibits and Reports on Form 8-K .........          9

       Signatures ..........................................          9

<PAGE>

                        PART I. FINANCIAL INFORMATION

 Item 1. Financial Statements

                         AMERICAN HEALTHCHOICE, INC.
                               AND SUBSIDIARIES

                          CONSOLIDATED BALANCE SHEET
                                 (Unaudited)
                                JUNE 30, 2003

                                   ASSETS

 Current Assets:
 Cash                                                         $      3,219
 Accounts receivable, less  allowance for doubtful
    accounts of $6,404,867                                       5,940,499
 Other current assets                                               79,820
                                                               -----------
      Total current assets                                       6,023,538

 Property and equipment, net                                       341,287
 Goodwill, net                                                   2,348,570
                                                               -----------
      Total assets                                            $  8,713,395
                                                               ===========

                  LIABILITIES AND STOCKHOLDERS' EQUITY

 Current Liabilities:
 Notes payable and capital lease obligation                   $    940,010
 Convertible debentures                                          1,310,400
 Bankruptcy claims                                               1,166,150
 Accrued payroll and payroll taxes                                 509,193
 Accounts payable and accrued expenses                             370,234
                                                               -----------
      Total current liabilities                                  4,295,987


 Commitments                                                             _

 Stockholders' Equity:
 Preferred stock, $.001 par value; 5,000,000 shares
   authorized; none issued                                               -
 Common stock, $.001 par value; 115,000,000 shares
   authorized; 88,100,766 shares issued and outstanding             88,100
 Options to acquire common stock                                     8,000
 Additional paid-in capital                                     20,534,684
 Accumulated deficit                                           (16,213,376)
                                                               -----------
      Total stockholders' equity                                 4,417,408
                                                               -----------
      Total liabilities and stockholders' equity              $  8,713,395
                                                               ===========

      See accompanying notes to these consolidated financial statements.

<PAGE>
<TABLE>

                         AMERICAN HEALTHCHOICE, INC.
                               AND SUBSIDIARIES

                    CONSOLIDATED STATEMENTS OF OPERATIONS
                                 (Unaudited)



                                     Three Months Ended June 30,        Nine Months Ended June 30,
                                    -----------------------------      ---------------------------
                                       2002             2003              2002             2003
                                    ----------       ----------        ----------       ----------
 <S>                               <C>              <C>               <C>              <C>
 Revenues:
   Patient billings                $ 2,100,238      $  1,972,18       $ 6,089,686      $ 5,897,304
   Allowance for discount
     on billings                       843,062          885,962         2,374,117        2,623,780
                                    ----------       ----------        ----------       ----------
     Net revenues                    1,257,176        1,086,226         3,715,569        3,273,524

 Operating Expenses:
   Compensation and benefits           751,169          698,529         2,179,203        2,050,879
   Depreciation and amortization        42,807            7,782           128,751           23,346
   General and administrative          421,093          361,887         1,208,783        1,139,896
   Rent                                 98,441           86,346           294,011          263,054
                                    ----------       ----------        ----------       ----------
      Total operating expenses       1,313,510        1,154,544         3,810,748        3,477,175

 Other Income (Expense):
   Interest expense and other
     costs of borrowing                (20,964)         (18,268)          (61,548)         (53,114)
   Other income                         95,477                -            95,477                -
                                    ----------       ----------        ----------       ----------
      Total other income (expense)      74,513          (18,268)           33,929          (53,114)
                                    ----------       ----------        ----------       ----------
 Net Income (Loss)                 $    18,179      $   (86,586)      $   (61,250)     $  (256,765)
                                    ==========       ==========        ==========       ==========

 Basic and Diluted Net Income
   (Loss) Per Share                $         -      $         -       $         -      $         -


 Weighted Average Common Shares
   Outstanding                      93,825,766       88,100,766        93,825,766       88,100,766


      See accompanying notes to these consolidated financial statements.

</TABLE>
<PAGE>

                              AMERICAN HEALTHCHOICE, INC.
                                   AND SUBSIDIARIES

                         CONSOLIDATED STATEMENTS OF CASH FLOWS
                                      (Unaudited)


                                                   Nine Months Ended June 30,
                                                   --------------------------
                                                        2002         2003
                                                      ---------    ---------
 Cash Flows From Operating Activities:
 Net loss                                            $  (61,250)  $ (256,765)
 Adjustments to reconcile net loss to net cash
   provided by (used in) operating activities:
   Allowance for doubtful accounts                    2,355,477    2,623,780
   Employee compensation-stock                           65,700       36,000
   Depreciation and amortization                        128,751       23,352
 Change in operating assets and liabilities, net:
   Accounts receivable-trade                         (2,609,196)  (2,455,031)
   Other current assets                                 (19,490)      (4,356)
   Accounts payable and accrued expenses                122,394       56,828
                                                      ---------    ---------
        Net cash provided by (used in)
          operating activities                          (17,614)      23,808

 Cash Flows From Investing Activities:
   Property and equipment                               (29,415)     (53,939)
                                                      ---------    ---------
        Net cash used in investing activities           (29,415)     (53,939)

 Cash Flows From Financing Activities:
   Proceeds from notes payable                           56,180       23,254
   Payments on notes payable and capital leases         (17,369)      (1,200)
                                                      ---------    ---------
        Net cash provided by financing activities        38,811       22,054
                                                      ---------    ---------
 Net Decrease In Cash                                    (8,218)      (8,077)
 Cash At Beginning Of Year                               37,303       11,296
                                                      ---------    ---------
 Cash At End Of Period                               $   29,085   $    3,219
                                                      =========    =========

 Supplemental Disclosure Of Cash Flow Information:
   Income taxes paid                                 $      610   $    2,000
   Interest paid                                          4,500        2,000

 Supplemental Disclosure of Non-Cash Transactions:
   Offset reduction in valuation of clinic assets
     acquired against goodwill                          330,000            -


      See accompanying notes to these consolidated financial statements.

<PAGE>

                         AMERICAN HEALTHCHOICE, INC.
                               AND SUBSIDIARIES

                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 1.   Organization

 American HealthChoice, Inc.  and subsidiaries  (the Company)  consists of  a
 parent company and thirteen clinics providing medical, physical therapy, and
 chiropractic services in  San Antonio, McAllen,  Laredo, San Benito,  Corpus
 Christi and Houston, Texas, and New  Orleans, Louisiana.  Substantially  all
 of the Company's  revenues are derived  from chiropractic, physical  therapy
 and medical services provided to individuals  living in the vicinity of  the
 clinics.


 2.   Basis of Presentation

 The accompanying unaudited interim consolidated financial statements of  the
 Company  have  been  prepared  pursuant  to  the  rules  and  regulations of
 the Securities and Exchange  Commission.  Certain  information  in  footnote
 disclosures normally included in financial statements prepared in accordance
 with generally accepted accounting principles have been condensed or omitted
 pursuant to these rules and regulations. The accompanying unaudited  interim
 consolidated financial statements reflect all adjustments which the  Company
 considers necessary for a fair presentation of the results of operations for
 the interim periods covered and for  the financial condition of the  Company
 at the date of the interim balance  sheet.  All such adjustments (except  as
 otherwise disclosed herein) are of a normal recurring nature.

 The results of operations for  the nine months ended  June 30, 2003 are  not
 necessarily indicative of the results to be expected for the full  year.  It
 is suggested  that  the June  30,  2003  financial information  be  read  in
 conjunction with the financial statements and notes thereto included in  the
 Company's Form 10-KSB dated September 30, 2002.


 3.    Summary of Significant Accounting Policies

 Consolidation policy  - The  accompanying condensed  consolidated  financial
 statements  include  the  accounts  of  the  Company  and  its  wholly-owned
 subsidiaries.  All  material  inter-company accounts  and transactions  have
 been eliminated in consolidation.

 Net  revenues  -  Revenue  is  recognized  upon  performance  of   services.
 Substantially all  of  the  Company's  revenues  are  derived  from  patient
 insurance settlements,  claims filed  on  major medical  policies,  worker's
 compensation policies, Medicare, and Medicaid.  Allowances for discounts  on
 services provided  are recognized  in the  periods  the related  revenue  is
 earned.  Allowances  are  maintained  at  levels considered  appropriate  by
 management based  upon historical  charge-off experience  and other  factors
 deemed pertinent by  management.  The  Company has no  contracts with  third
 party payors that would require the disclosure of the amount of  contractual
 adjustments.

 Property and equipment, net - Property and equipment are stated at cost less
 accumulated  depreciation.  Depreciation  is  provided  over  the  estimated
 useful lives  of  the  related assets,  primarily  using  the  straight-line
 method.  Leasehold improvements are amortized over the shorter of the  lease
 term or the estimated useful lives of the improvements.

 Goodwill -  The  Company  elected  to  adopt  the  provisions  of  Financial
 Accounting Standard ("FAS") 142, "Goodwill  and Other Intangible Assets"  as
 of  October  1, 2001.  This  policy requires  an impairment  test, which  is
 performed by the Company on an annual basis.

 Earnings per  share  - Basic  earnings  per  share are  computed  using  the
 weighted-average number of common shares outstanding.  Diluted earnings  per
 share are  computed using  the  weighted-average common  shares  outstanding
 after giving effect to  potential common stock from  stock options based  on
 the treasury  stock  method,  plus  other  potentially  dilutive  securities
 outstanding.  If the result of assumed conversions is dilutive, net earnings
 are adjusted for  the interest expense  on the convertible  debt, while  the
 average shares of common stock outstanding are increased.


 4.    Goodwill

 The Company elected to adopt the provisions of Financial Accounting Standard
 ("FAS") 142, "Goodwill and Other Intangible  Assets" as of October 1,  2001.
 This pronouncement addresses  the issue of  proper accounting and  reporting
 for intangible assets,  such as purchased  goodwill.  FAS  142 modified  the
 purchase method of  accounting by eliminating  the amortization of  goodwill
 and substituting an impairment  test.  For  testing purposes the  "reporting
 unit", as prescribed by FAS 142, is the three clinics acquired in  September
 2000 for a total purchase price of $6,000,000.

 For the twelve month period ended  September 30, 2002, operating income  for
 the reporting unit was  $163,000 compared to $927,000  for the twelve  month
 period  ended  September  30,  2001.  Due  to  the  substantial  decline  in
 operating income,  the  Company engaged  an  independent valuation  firm  to
 conduct the impairment test as of September  30, 2002.  Based on the  income
 approach, in the opinion of the  independent valuation firm, the fair  value
 of the net assets of the reporting unit was $4,000,000.  Since the  carrying
 value of  the  reporting  unit was  approximately  $4,900,000,  the  Company
 elected to record an impairment loss of $900,000.

 The primary assumption used for the income approach was an average operating
 income of approximately $400,000 per year for the five years commencing with
 the fiscal year ending September 30, 2003.  Operating income for these three
 clinics  for the first  nine months of fiscal  2003 was $75,000.  Management
 has taken  steps to  increase patient  billings at  these three  clinics  by
 increasing the  number  of  new patients  and  concurrently  increasing  the
 average billing  per case.  Based  on  this  projected increase  in  patient
 billings and already implemented reductions in operating expenses, the three
 clinics should recognize operating income of approximately $200,000 for  the
 fiscal  year  ending  September  30,  2003.  Management  believes  that  the
 reporting unit should achieve operating income of approximately $400,000  in
 fiscal year 2004 and subsequent years.  Therefore, recognition of a  further
 impairment to the carrying  value of the reporting  unit is not required  at
 this time.


 Item 2.   Management's Discussion and Analysis or Plan of Operation

 Results of Operations

 The following discussion and analysis should be read in conjunction with the
 Consolidated Financial Statements and Notes thereto, and is qualified in its
 entirety by the foregoing and by  other more detailed financial  information
 appearing elsewhere.

 Three Months Ended  June 30, 2003  Compared to Three  Months Ended June  30,
 2002

      Patient Billings.  For  the three months ended  June 30, 2003,  patient
 billings  decreased  from $2,100,000  in 2002  to $1,972,000  in  2003.  The
 decrease is primarily attributable to a decrease in patient billings for the
 clinics acquired in September 2000 in the amount of $54,000.

      Allowance for Discount on  Billings.  For the  three months ended  June
 30, 2003, allowance for discount on billings increased from $843,000 for the
 same  period  in  2002  to $886,000  in  2003.  The  increase  is  primarily
 attributable to an  upward adjustment in  the allowance as  a percentage  of
 patient billings from 40% in the 2002 period to 45% in the 2003 period.  The
 adjustment reflects an increase in the  number of new personal injury  cases
 written off in  the 2003 period  due primarily to  the absence of  insurance
 coverage.  The collection percentage on cases that were settled by patient's
 attorneys in 2003 was comparable to 2002.

      Compensation and Benefits.  For the  three months ended June 30,  2003,
 compensation and benefits  decreased from $751,000  in 2002  to $699,000  in
 2003.  The decrease  is primarily attributable to  salary reductions at  the
 clinics acquired in September 2000 in the amount of $35,000.  The number  of
 clinic employees is unchanged in the 2003 period compared to the same period
 in 2002.

      Depreciation and Amortization.   For the  three months  ended June  30,
 2003, depreciation and amortization decreased from $43,000 in 2002 to $8,000
 in 2003.  The decrease is  primarily due to amortization of financing  costs
 in  the  amount of  $22,000 in  the 2002  period.  The  2003 period  has  no
 amortization of  financing costs  since the  costs were  amortized in  prior
 years.

      General and Administrative.  For the three months ended June 30,  2003,
 general and administrative decreased  from $421,000 in  2002 to $362,000  in
 2003.  The decrease is primarily attributable to reductions in  professional
 and insurance expense at the corporate office in the amount of $29,000 and a
 decrease in miscellaneous expenses at the clinics in the amount of $22,000.

      Rent.   For the  three months  ended June  30, 2003,  rent was  $86,000
 compared  to  $98,000  in  the  2002  period.   The  decrease  is  primarily
 attributable to  the  Company  moving its  corporate  office  to  a  smaller
 location at the end of January 2003.  The monthly savings are  approximately
 $5,000 per month.

      Other Income.    The  2002  period  includes  $95,000  from  a  lawsuit
 settlement.

 Nine Months Ended June 30, 2003 Compared to Nine Months Ended June 30, 2002

      Patient Billings.   For the nine  months ended June  30, 2003,  patient
 billings  decreased  from $6,090,000  in 2002  to $5,897,000  in  2003.  The
 decrease is primarily attributable to a decrease in patient billings for the
 clinics acquired  in  September 2000  in  the  amount of  $378,000  and  the
 Louisiana clinics in the amount of $110,000 offset by an increase in patient
 billings for the other Texas chiropractic clinics of approximately $390,000.

      Allowance for Discount on Billings.  For the nine months ended June 30,
 2003, allowance for discount on billings  increased from $2,374,000 for  the
 same period in 2002 to $2,624,000 in 2003.  The increase is attributable  to
 an upward adjustment in  the allowance as a  percentage of patient  billings
 from  39% in  the 2002  period to 44%  in the  2003 period.  The  adjustment
 reflects an increase in the number of new personal injury cases written  off
 in  the 2003 period due primarily to the absence of insurance coverage.  The
 collection percentage on cases that were  settled by patient's attorneys  in
 2003 is comparable to 2002.

      Compensation and Benefits.   For the nine months  ended June 30,  2003,
 compensation and benefits decreased from $2,179,000 in 2002 to $2,051,000 in
 2003.  The decrease  is primarily attributable to  salary reductions at  the
 clinics acquired in September 2000 in the amount of $125,000.  The number of
 clinic employees is unchanged in the 2003 period compared to the same period
 in 2002.

      Depreciation and  Amortization.   For the  nine months  ended June  30,
 2003, depreciation  and  amortization decreased  from  $129,000 in  2002  to
 $23,000  in  2003.  The  decrease  was  primarily  due  to  amortization  of
 financing costs in  the amount  of $66,000  in the  2002  period.  The  2003
 period has no amortization of financing costs since the costs were amortized
 in prior years.

      General and Administrative.  For the  nine months ended June 30,  2003,
 general and administrative decreased from  $1,209,000 in 2002 to  $1,140,000
 in 2003.  The decrease is primarily attributable to reductions in rental and
 insurance expense at the corporate office in the amount of $65,000.

      Rent.   For the  nine months  ended June  30, 2003,  rent was  $263,000
 compared  to  $294,000  in  the  2002  period.  The  decrease  is  primarily
 attributable to  the  Company  moving its  corporate  office  to  a  smaller
 location at the end of January 2003.  The monthly savings are  approximately
 $5,000 per month.

      Other Income.    The  2002  period  includes  $95,000  from  a  lawsuit
 settlement.


 Liquidity and Capital Resources

 For the nine  months ended  June 30, 2003,  net cash  provided by  operating
 activities  was  $24,000  compared  to net cash used in operating activities
 in  the  amount of $17,000  for  the nine months  ended June 30,  2002.  Net
 cash provided  by  operating  activities  in the  2003  period is  primarily
 attributable to non-cash expenses in the amount of $2,624,000 for  allowance
 for doubtful accounts  offset by  a net loss  of $256,000  and a  $2,455,000
 increase in accounts receivable.  Net  cash used in operating activities  in
 the 2002 period is primarily attributable to  a net loss of $61,000 plus  an
 increase in accounts receivable in the  amount of $2,609,000 offset by  non-
 cash expenses in the  amount of $2,355,000 for  doubtful  accounts.  Capital
 expenditures were financed by proceeds from notes payable.

 During the year ended September 30, 2002, cash generated from operations was
 sufficient to  meet  current  obligations  including  capital  expenditures.
 However, funds were not available to satisfy bankruptcy plan payments due in
 September 2001 and September  2002.  At September  30, 2002 the Company  was
 delinquent on payments due to unsecured  creditor claims and insider  claims
 in the amounts  of $356,000 and  $440,000,  respectively.  In addition,  the
 loan in the amount of $837,000 issued in connection with the acquisition  of
 three clinics in September  2000 was due and  payable on September 1,  2002.
 The amount past due including unpaid interest is approximately $1,026,000.

 In the  case of  the bankruptcy  payments, fewer  than five  creditors  have
 pursued collection of claims due as of September 30, 2002.  The Company  was
 able to meet  these payments and  avoid legal action  on the  part of  these
 creditors.  At the present time, Management does not foresee any  individual
 creditors initiating legal action in regards to past due payment of  claims.
 However, there are  no assurances that  an individual creditor  or group  of
 creditors will  not  pursue  legal action  which  could  result  in  adverse
 consequences to the Company.

 For the nine months ended June 30, 2003, collections of patient billings was
 $3,482,000 compared to $3,474,000 for the  nine months ended June 30,  2002.
 As  a  result,  the  Company  was  able  to  meet obligations  for the first
 nine months of  the current  fiscal  year.  However,  patient billings,  net
 of  allowance  for  discounts, declined  from $3,716,000  to $3,274,000  for
 the  comparable  periods,  respectively.  Net  revenues  must  increase   to
 approximately $400,000 per month for the Company  to meet its obligations in
 the  future.  In this regard,  Management continues to  focus on  increasing
 payments on  personal injury  case settlements  and increase  the number  of
 worker's compensation cases, which result  in higher settlement amounts  per
 case compared to personal injury cases.  In  addition, efforts are  underway
 to reduce marketing costs at the San Antonio clinics.  As a result of  these
 and other actions  to improve cash  flow, overall  liquidity should  improve
 during the remaining three months of fiscal 2003.

 Before September  1, 2003,  Management expects  to  amend the  note  payable
 issued in connection  with the  acquisition of  three clinics  to allow  for
 payment over a longer period of time.


 Forward-Looking Information

 This report  contains  certain forward-looking  statements  and  information
 relating to  the Company  that are  based on  the beliefs  of the  Company's
 management  as  well  as  assumptions  made  by  and  information  currently
 available to the Company's management. When  used in the report, words  such
 as "anticipate," "believe,"  "estimate," "expect,"  "intend," "should,"  and
 similar expressions,  as  they relate  to  the Company  or  its  management,
 identify  forward-looking statements.  Such statements  reflect the  current
 views of  the Company  with respect  to  future events  and are  subject  to
 certain risks, uncertainties,  and assumptions relating  to the  operations,
 results of  operations,  liquidity,  and growth  strategy  of  the  Company,
 including competitive factors  and pricing pressures,  changes in legal  and
 regulatory requirements, interest  rate fluctuations,  and general  economic
 conditions, as well as other factors  described in this report.  Should  one
 or more of  the risks materialize,  or should  underlying assumptions  prove
 incorrect, actual  results  or  outcomes  may  vary  materially  from  those
 described herein as anticipated, believed, estimated, expected, or intended.


                         Part II.  OTHER INFORMATION

 Item 1.  Legal Proceedings

 There have been no material events  related to legal proceedings during  the
 quarter ended June 30, 2003 and  there have been no material events  related
 to legal proceedings reported  in the Registrants  10-KSB filed January  14,
 2003.


 Item 2.  Changes in Securities and Use of Proceeds

 Not applicable


 Item 3.  Defaults upon Senior Securities

 None to report


 Item 4.   Submission of matters to a vote of security holders

 None to report


 Item 5.  Other Information

 None


 Item 6.  Exhibits and Reports on Form 8-K

 31.1      Certification pursuant to Section 302 of The Sarbanes-Oxley Act
           of 2002 for Dr. J. W. Stucki, President and Chief Executive
           Officer.

 31.1      Certification pursuant to Section 302 of The Sarbanes-Oxley Act
           of 2002 for John C. Stuecheli, Vice President and Chief Financial
           Officer.

 32.1      Certification pursuant to 18 U.S.C. Section 1350, as adopted
           pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for Dr.
           J. W. Stucki, President and Chief Executive Officer.

 32.2      Certification pursuant to 18 U.S.C. Section 1350, as adopted
           pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 for John
           C. Stuecheli, Vice President and Chief Financial Officer.

 No Form 8-K Reports were filed during the quarter ended June 30, 2003.


<PAGE>

                               SIGNATURES

      In accordance with Section 13 or  15(d) of the Securities Exchange  Act
 of 1934, the Registrant caused this Report to be signed on its behalf by the
 undersigned, thereunto duly authorized.



                               AMERICAN HEALTHCHOICE, INC.

 Date: August 13, 2003         By:  /s/ Dr. J.W. Stucki
                               Dr. J.W. Stucki, Chief Executive
                               Officer and President

 Date: August 13, 2003         By:  /s/John C. Stuecheli
                               John C. Stuecheli, Chief Financial Officer and
                               Vice President - Finance
                               (Principal Financial and Accounting Officer)